205 related articles for article (PubMed ID: 17761945)
1. Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin m reduces hypertriglyceridemia through enhanced beta-oxidation.
Zhou Y; Abidi P; Kim A; Chen W; Huang TT; Kraemer FB; Liu J
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2198-205. PubMed ID: 17761945
[TBL] [Abstract][Full Text] [Related]
2. Reduction of serum free fatty acids and triglycerides by liver-targeted expression of long chain acyl-CoA synthetase 3.
Wu M; Cao A; Dong B; Liu J
Int J Mol Med; 2011 May; 27(5):655-62. PubMed ID: 21347510
[TBL] [Abstract][Full Text] [Related]
3. Long chain acyl-CoA synthetase-3 is a molecular target for peroxisome proliferator-activated receptor delta in HepG2 hepatoma cells.
Cao A; Li H; Zhou Y; Wu M; Liu J
J Biol Chem; 2010 May; 285(22):16664-74. PubMed ID: 20308079
[TBL] [Abstract][Full Text] [Related]
4. Janus kinase activation by cytokine oncostatin M decreases PCSK9 expression in liver cells.
Cao A; Wu M; Li H; Liu J
J Lipid Res; 2011 Mar; 52(3):518-30. PubMed ID: 21196532
[TBL] [Abstract][Full Text] [Related]
5. Hepatic expression of long-chain acyl-CoA synthetase 3 is upregulated in hyperlipidemic hamsters.
Wu M; Liu H; Chen W; Fujimoto Y; Liu J
Lipids; 2009 Nov; 44(11):989-98. PubMed ID: 19756806
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin M activates low density lipoprotein receptor gene transcription in sterol-repressed liver cells.
Liu J; Grove RI; Vestal RE
Cell Growth Differ; 1994 Dec; 5(12):1333-8. PubMed ID: 7696181
[TBL] [Abstract][Full Text] [Related]
7. Hepatic long-chain acyl-CoA synthetase 5 mediates fatty acid channeling between anabolic and catabolic pathways.
Bu SY; Mashek DG
J Lipid Res; 2010 Nov; 51(11):3270-80. PubMed ID: 20798351
[TBL] [Abstract][Full Text] [Related]
8. In vivo activities of cytokine oncostatin M in the regulation of plasma lipid levels.
Kong W; Abidi P; Kraemer FB; Jiang JD; Liu J
J Lipid Res; 2005 Jun; 46(6):1163-71. PubMed ID: 15772430
[TBL] [Abstract][Full Text] [Related]
9. Rat long chain acyl-CoA synthetase 5 increases fatty acid uptake and partitioning to cellular triacylglycerol in McArdle-RH7777 cells.
Mashek DG; McKenzie MA; Van Horn CG; Coleman RA
J Biol Chem; 2006 Jan; 281(2):945-50. PubMed ID: 16263710
[TBL] [Abstract][Full Text] [Related]
10. Molecular dissection of human oncostatin M-mediated signal transductions through site-directed mutagenesis.
Liu H; Fenollar-Ferrer C; Cao A; Anselmi C; Carloni P; Liu J
Int J Mol Med; 2009 Feb; 23(2):161-72. PubMed ID: 19148539
[TBL] [Abstract][Full Text] [Related]
11. Lipid-induced up-regulation of human acyl-CoA synthetase 5 promotes hepatocellular apoptosis.
Reinartz A; Ehling J; Leue A; Liedtke C; Schneider U; Kopitz J; Weiss T; Hellerbrand C; Weiskirchen R; Knüchel R; Gassler N
Biochim Biophys Acta; 2010 Sep; 1801(9):1025-35. PubMed ID: 20470896
[TBL] [Abstract][Full Text] [Related]
12. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
[TBL] [Abstract][Full Text] [Related]
13. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity.
Bu SY; Mashek MT; Mashek DG
J Biol Chem; 2009 Oct; 284(44):30474-83. PubMed ID: 19737935
[TBL] [Abstract][Full Text] [Related]
14. PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro.
Kan CF; Singh AB; Dong B; Shende VR; Liu J
Biochim Biophys Acta; 2015 May; 1851(5):577-87. PubMed ID: 25645621
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo.
Parkes HA; Preston E; Wilks D; Ballesteros M; Carpenter L; Wood L; Kraegen EW; Furler SM; Cooney GJ
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E737-44. PubMed ID: 16705061
[TBL] [Abstract][Full Text] [Related]
16. Effect of polyphenol-rich extract from walnut on diet-induced hypertriglyceridemia in mice via enhancement of fatty acid oxidation in the liver.
Shimoda H; Tanaka J; Kikuchi M; Fukuda T; Ito H; Hatano T; Yoshida T
J Agric Food Chem; 2009 Mar; 57(5):1786-92. PubMed ID: 19256553
[TBL] [Abstract][Full Text] [Related]
17. Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis.
Padanad MS; Konstantinidou G; Venkateswaran N; Melegari M; Rindhe S; Mitsche M; Yang C; Batten K; Huffman KE; Liu J; Tang X; Rodriguez-Canales J; Kalhor N; Shay JW; Minna JD; McDonald J; Wistuba II; DeBerardinis RJ; Scaglioni PP
Cell Rep; 2016 Aug; 16(6):1614-1628. PubMed ID: 27477280
[TBL] [Abstract][Full Text] [Related]
18. ACSL5 genotype influence on fatty acid metabolism: a cellular, tissue, and whole-body study.
Rajkumar A; Liaghati A; Chan J; Lamothe G; Dent R; Doucet É; Rabasa-Lhoret R; Prud'homme D; Harper ME; Tesson F
Metabolism; 2018 Jun; 83():271-279. PubMed ID: 29605434
[TBL] [Abstract][Full Text] [Related]
19. Regulation of enterocyte apoptosis by acyl-CoA synthetase 5 splicing.
Gassler N; Roth W; Funke B; Schneider A; Herzog F; Tischendorf JJ; Grund K; Penzel R; Bravo IG; Mariadason J; Ehemann V; Sykora J; Haas TL; Walczak H; Ganten T; Zentgraf H; Erb P; Alonso A; Autschbach F; Schirmacher P; Knüchel R; Kopitz J
Gastroenterology; 2007 Aug; 133(2):587-98. PubMed ID: 17681178
[TBL] [Abstract][Full Text] [Related]
20. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
